These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 17139667)
1. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Ng KP; Manson JJ; Rahman A; Isenberg DA Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667 [TBL] [Abstract][Full Text] [Related]
2. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease. Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases. Půtová I; Dostal C; Becvar R Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316 [TBL] [Abstract][Full Text] [Related]
5. Antinucleosome antibodies and systemic lupus erythematosus. Düzgün N; Sahin M; Genç Y; Tutkak H Ann N Y Acad Sci; 2007 Aug; 1109():421-8. PubMed ID: 17785331 [TBL] [Abstract][Full Text] [Related]
6. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152 [TBL] [Abstract][Full Text] [Related]
7. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Mok CC; Ho LY; Leung HW; Wong LG Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493 [TBL] [Abstract][Full Text] [Related]
8. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702 [TBL] [Abstract][Full Text] [Related]
9. Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus. Wu JF; Yang YH; Wang LC; Lee JH; Shen EY; Chiang BL J Autoimmun; 2006 Sep; 27(2):119-24. PubMed ID: 16919912 [TBL] [Abstract][Full Text] [Related]
10. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? Andreoli L; Pregnolato F; Burlingame RW; Allegri F; Rizzini S; Fanelli V; Radice A; Corace C; Sinico RA; Meroni PL; Tincani A J Autoimmun; 2008; 30(1-2):51-7. PubMed ID: 18191541 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies. Gutiérrez-Adrianzén OA; Koutouzov S; Mota RM; das Chagas Medeiros MM; Bach JF; de Holanda Campos H J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863 [TBL] [Abstract][Full Text] [Related]
12. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus. Steiman AJ; Urowitz MB; Ibañez D; Li TT; Gladman DD; Wither J J Rheumatol; 2015 May; 42(5):810-6. PubMed ID: 25729033 [TBL] [Abstract][Full Text] [Related]
13. A surge in anti-dsDNA titer predicts a severe lupus flare within six months. Pan N; Amigues I; Lyman S; Duculan R; Aziz F; Crow MK; Kirou KA Lupus; 2014 Mar; 23(3):293-8. PubMed ID: 24316605 [TBL] [Abstract][Full Text] [Related]
14. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Ho A; Magder LS; Barr SG; Petri M Arthritis Rheum; 2001 Oct; 44(10):2342-9. PubMed ID: 11665975 [TBL] [Abstract][Full Text] [Related]
15. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial. Tseng CE; Buyon JP; Kim M; Belmont HM; Mackay M; Diamond B; Marder G; Rosenthal P; Haines K; Ilie V; Abramson SB Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807 [TBL] [Abstract][Full Text] [Related]
16. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus. Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326 [TBL] [Abstract][Full Text] [Related]
18. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies. Pradhan VD; Patwardhan MM; Ghosh K Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543 [TBL] [Abstract][Full Text] [Related]
19. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis. Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514 [TBL] [Abstract][Full Text] [Related]
20. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus. Almogren A Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]